Parmax Pharma
Company Overview - January 14, 2025
Parmax Pharma is a notable player in the Pharmaceuticals - Indian - Bulk Drugs industry, listed on the BSE (Code: 540359). As of the January 14, 2025, the company holds a market capitalization of INR 17.58 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 47.00, Parmax Pharma has demonstrated a 60.34% return over the last year. Recent performance indicates fluctuations, with a 6.52% change in the past week and a 6.41% change over the last month. The company's all-time high stands at INR 81.90, while its lowest-ever price was INR 12.50.
In terms of sales, Parmax Pharma reported a revenue of INR 22.69 crores, solidifying its position in the market. The average trading volume over the past month has been 1009 shares, with a more recent weekly average of 753.
With the stock trading above its 50-day moving average of INR 44.44, the company's technical indicators like MACD (0.85) signal negative trends.
Company Data
| Name | Parmax Pharma |
|---|---|
| BSE Code | 540359 |
| NSE Code | |
| Industry | Pharmaceuticals - Indian - Bulk Drugs |
| Current Price | 47.00 |
| Market Capitalization | 17.58 |
| Sales | 22.69 |
| Return over 3months | 38.81 |
| Return over 6months | 61.08 |
| Volume 1month average | 1009 |
| Volume 1week average | 753 |
| Volume | 481 |
| High price | 54.00 |
| Low price | 24.18 |
| High price all time | 81.90 |
| Low price all time | 12.50 |
| Return over 1day | -4.08 |
| Return over 1week | 6.52 |
| Return over 1month | 6.41 |
| Return over 1year | 60.34 |
| Return over 3years | 6.56 |
| Return over 5years | 21.77 |
| Volume 1year average | 3006 |
| DMA 50 | 44.44 |
| DMA 200 | 37.79 |
| DMA 50 previous day | 44.26 |
| DMA 200 previous day | 37.68 |
| MACD | 0.85 |
| MACD Signal | 1.10 |